Heart Foundation’s Post

If you watch football on TV, you might have seen it before: out of nowhere a seemingly healthy athlete collapses onto the field. This is how Sudden Cardiac Death (SCD) strikes. Coronary artery anomalies (CAA), like anomalous aortic origin of coronary artery (AAOCA) and myocardial bridges (MB) are associated with Sudden Cardiac Death, with AAOCA being a leading cause of SCD in young athletes. But while the association is clear, the diagnosis and management of these conditions are not. Can patients even risk exercise after a diagnosis? Are the methods of diagnosis clear enough to merit ending an athlete’s career for good? If you’re interested the answers to these questions and learning more about CAA, join me and my colleagues as we host the 6th annual Coronary Artery Anomalies Symposium, December 5th – 7th. There we will discuss the challenges of diagnosing and managing these conditions, how to use advanced imaging modalities to accurately diagnose them, dig into the risk factors and more. Learn more about this event and RSVP here: https://lnkd.in/gHNT-5rf

Dr. Jason Kovacic discusses his paper comparing the current peripheral transradial trajectory to the coronary space in the mid-2000s, highlighting the benefits of radial access. 'What we know from the coronary field is radial access is patient-preferred, it reduces bleeding complications, it’s safer, and in some contexts it can actually improve mortality and significant outcomes,' Dr. Kovacic said. https://lnkd.in/gCMK-VE9

Attn: Early-Career Interventionalists and Mentors! Listen in to this 20-minute discussion with Drs. Morton Kern, David Rizik, Jennifer Rymer, and Pinak Shah, as they dive into Dr. Rymer's study on cath lab procedure volumes and outcomes among early-career interventional cardiologists, and Dr. Shah's accompanying editorial, "Is There an Experience/Exposure Paradox in Interventional Cardiology?" https://okt.to/QF92rD

💥 1st trans jugular mitral transcatheter edge-to-edge repair using the PASCAL system in Europe 🇪🇺 at CHU de Lille ➡️ No other option for this prohibitive surgical risk patient with severe scoliosis and very good results with 2 PASCAL Ace (residual MR 1+ and mean gradient 3.8mmHg) 🔎 An alternative solution for selected patients? 🙏 Thanks to all the people from our institution involved in the project Arnaud Sudre Gilles Lemesle NATACHA ROUSSE André Vincentelli David Montaigne François Ascagne PONTANA Emmanuel Robin Philippine Alphand (and people from the Cath lab, the ICCU and the Cardiology Department, I'm sure I'm forgetting a few) as well as people from Edwards Lifesciences for their help Renaud Brocheray Nathalie Granier Rania Shahbaz Piero Ocone Anja Buytaert Christy Purnajo Insaf Arfaoui Jean-Paul Herzog Juan Guinea Viniegra Neal Uren 🎄 And of course, on behalf of the Heart Team, we wish you all an happy holiday season!

Cardiac safety testing is an important part of the approval of new chemical entities (NCEs). During the last 20 years cardiac safety testing has been focused on QT interval assessment as a surrogate for the potential of an NCE to cause “Torsade de Pointes” - a specific life-threatening ventricular arrhythmia that is potentially associated with QT interval prolongation. However, these analyses have been conducted using limited, short-term data in a resting state. Newer technologies allow for the collection of long-term data in a more dynamic, real-world setting. Join ICON’s cardiac safety experts Dr. Polina Voloshko and Dr. Timothy Callahan who will discuss how long-term cardiovascular data can support a cardiac safety portfolio, exploring new cardiac monitoring technologies and their applications, and methods of data collection and analysis. Register here: https://ow.ly/tLHH50Tghyn

Cardiac safety testing is an important part of the approval of new chemical entities (NCEs). During the last 20 years cardiac safety testing has been focused on QT interval assessment as a surrogate for the potential of an NCE to cause “Torsade de Pointes” - a specific life-threatening ventricular arrhythmia that is potentially associated with QT interval prolongation. However, these analyses have been conducted using limited, short-term data in a resting state. Newer technologies allow for the collection of long-term data in a more dynamic, real-world setting. Join ICON’s cardiac safety experts Dr. Polina Voloshko and Dr. Timothy Callahan who will discuss how long-term cardiovascular data can support a cardiac safety portfolio, exploring new cardiac monitoring technologies and their applications, and methods of data collection and analysis. Register here: https://ow.ly/tLHH50Tghyn

We are very pleased to share with you our publication on the external validity of a prognostic score in TGA with atrial switch and on the importance of subpulmonary left ventricular assessment in patients with a systemic right ventricle, which has just been published in JAHA - Magalie Ladouceur, Victor Waldmann, Fabien Labombarda, Flavia Fusco, Berardo Sarubbi

Cardiac safety testing is an important part of the approval of new chemical entities (NCEs). During the last 20 years cardiac safety testing has been focused on QT interval assessment as a surrogate for the potential of an NCE to cause “Torsade de Pointes” - a specific life-threatening ventricular arrhythmia that is potentially associated with QT interval prolongation. However, these analyses have been conducted using limited, short-term data in a resting state. Newer technologies allow for the collection of long-term data in a more dynamic, real-world setting. Join ICON’s cardiac safety experts Dr. Polina Voloshko and Dr. Timothy Callahan who will discuss how long-term cardiovascular data can support a cardiac safety portfolio, exploring new cardiac monitoring technologies and their applications, and methods of data collection and analysis. Register here: https://ow.ly/tLHH50Tghyn

Cardiac safety testing is an important part of the approval of new chemical entities (NCEs). During the last 20 years cardiac safety testing has been focused on QT interval assessment as a surrogate for the potential of an NCE to cause “Torsade de Pointes” - a specific life-threatening ventricular arrhythmia that is potentially associated with QT interval prolongation. However, these analyses have been conducted using limited, short-term data in a resting state. Newer technologies allow for the collection of long-term data in a more dynamic, real-world setting. Join ICON’s cardiac safety experts Dr. Polina Voloshko and Dr. Timothy Callahan who will discuss how long-term cardiovascular data can support a cardiac safety portfolio, exploring new cardiac monitoring technologies and their applications, and methods of data collection and analysis. Register here: https://ow.ly/tLHH50Tghyn

I highly recommend this webinar. Dr. Voloshko and Dr. Callahan are very knowledgeable!